Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
AIDS Malignancy Consortium
Fox Chase Cancer Center